$1.78
Last update: Jul 10, 7:34 AM
GRI Bio Inc Earnings Estimates
GRINASDAQ
GRI Bio Earnings Estimates, EPS & Revenue | NASDAQ:GRI
GRI Bio (GRI) is scheduled to report Q2 earnings on August 13, 2026. Analysts estimate EPS of $-1.20 and quarterly revenue of N/A.
In the most recent quarter (Q1), GRI Bio reported EPS of $-1.61, beating estimates of $-3.17 by 0.49%. Revenue came in at $0, meeting the estimate of $0 by 0.00%.
GRI Bio has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, GRI Bio has averaged an EPS surprise of 0.40% and a revenue surprise of 0.00%.
Earnings Date
Aug 13
EPS Estimate
$-1.200
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
GRI Bio Earnings History
Analyze the earnings history of GRI Bio using advanced sorting and filters.
Loading calendar...
GRI Bio (GRI) Earnings Per Share
The chart below shows GRI Bio's reported EPS compared to analyst estimates over recent quarters.
GRI Bio (GRI) Revenue
The chart below shows GRI Bio's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is GRI Bio (NASDAQ:GRI) reporting earnings?
GRI Bio (GRI) is scheduled to report earnings on August 13, 2026. The last reported earnings were for reported on May 14, 2026 for Q1.
What were the latest earnings per share (EPS) for GRI Bio (NASDAQ:GRI)?
The Actual EPS was $-1.61, which beat the estimate of $-3.17.
What were GRI Bio’s (NASDAQ:GRI) revenues?
The Actual Revenue was $0, which hit the estimate of $0.
